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associated with the burden of CAD on cardiac catheter-
ization and with ruling in for myocardial infarction (MI).
METHODS
We performed a retrospective chart review on 156 con-
secutive adult patients presenting to the Montefiore 
Medical Center Emergency Department beginning on 
January 1, 2002, with symptoms of unstable angina and 
no known prior history of CAD who underwent cardiac 
catheterization as part of their index hospitalization. 
No known CAD was defined as: no known history of MI, 
percutaneous coronary intervention, or coronary artery 
bypass surgery. Additional exclusion criteria were: (1) 
cardiac catheterization within the previous six months, 
(2) serum creatinine > 3.0 mg/dl or hemodialysis, (3) 
a history of heart failure, or (4) other severe acute ill-
ness or organ failure. Admission history and laboratory 
data were obtained. Three patients were missing car-
diac enzymes. Creatinine clearance (CrCl) was calculated 
with the Cockcroft-Gault equation. Hyperlipidemia was 
defined as a history of hyperlipidemia or anti-hyperlip-
idemic medication use.  Diabetes was defined as a his-
tory of diabetes or anti-hyperglycemic medication use. 
Smoking was defined as any prior history of tobacco 
smoking. Hypertension (HTN) was defined as a history 
of HTN or anti-hypertensive medication use. Positive 
cardiac markers defined ruling in for MI. 
A priori, we developed a burden of CAD score, with 
higher values representing a greater burden of CAD, as 
described previously (Usberti et al., 1985).  We scored 
the burden of CAD as follows: (1) left main coronary 
artery; each individual stenosis of 20-49% was given a 
score of 0.5, 50-69%, 1.0, and >=70%, 1.5, respectively, 
(2) left anterior descending (LAD) artery system (which 
included the LAD and diagonals); each individual steno-
sis of 20-49% was given a score of 0.5, 50-69%, 1.0, and 
>=70%, 1.5, respectively, (3) left circumflex (LCx) system 
(which included the LCx and obtuse marginals); each 
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Renal dysfunction has been associated with adverse 
cardiovascular outcomes. Estimates of renal function 
routinely utilize creatinine-based measures. Serum 
blood urea nitrogen (BUN) levels, however, may provide 
supplemental information in regard to renal function 
as renal proximal tubule cells may increase BUN re-
absorption in the setting of increased neurohormonal 
activation. We performed a retrospective chart review 
on 156 consecutive adult patients presenting to the 
Montefiore Medical Center Emergency Department 
with symptoms of unstable angina and no known prior 
history of coronary artery disease (CAD) who underwent 
cardiac catheterization as part of their index hospital-
ization. On multivariate analysis, admission serum BUN 
was associated with an increased burden of CAD on 
cardiac catheterization and was not associated with 
ruling in for myocardial infarction (MI).
INTRODUCTION
Renal dysfunction has been associated with adverse car-
diovascular outcomes (McCullough, 2003; Dossetor, 1966; 
Conte et al., 1987; Aronson et al., 2004). In these studies 
and others, renal function has routinely been assessed 
with an estimated creatinine clearance, serum creati-
nine, or an estimated glomerular filtration rate derived 
from the serum creatinine (Suwaidi et al., 2002). 
Serum blood urea nitrogen (BUN) levels, however, may 
provide supplemental information in regard to renal 
function as renal proximal tubule cells may increase BUN 
reabsorption in the setting of increased neurohormonal 
activation (Shlipak et al., 2002). Accordingly, higher 
serum BUN has been associated with adverse outcomes 
in subjects with acute coronary syndromes (Levey et al., 
1999). We examined whether admission serum BUN in 
subjects presenting with symptoms of unstable angina 
and without known coronary artery disease (CAD) was 
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1.09 (1.01, 1.12); p=0.02). When MI status during index 
hospitalization was added to the multivariate model, 
the association of BUN and burden of CAD remained 
significant (p=0.05). 
Baseline characteristics for those who did and did not 
rule in for MI are presented in Table 3. Those subjects 
who ruled in for myocardial infarction had a lower body 
mass index (BMI) (27.0 mg/dl vs. 29.3 mg/dl, p=0.02), and 
a higher CAD burden score, (5.2 vs. 2.9, p<0.01), com-
pared with those who did not rule in for myocardial 
infarction.  
On univariate and multivariate analysis, an increased 
BUN was not associated with an increased odds of rul-
ing in for MI (OR 0.99 (0.07, 1.02); p=0.92) and (OR 0.99 
(0.96, 1.05); p=0.82), respectively. 
DISCUSSION
We found that elevated serum BUN on admission was 
associated with an increased burden of CAD on cardiac 
catheterization during index hospitalization in patients 
who presented with symptoms of unstable angina and 
without known cardiovascular disease. To the best of 
our knowledge, this study is the first to demonstrate 
this association. Furthermore, each 1mg/dl increase in 
BUN was associated with an increased burden of CAD. 
Admission BUN, however, was not associated with ruling 
in for myocardial infarction. 
Blood urea nitrogen may have pro-atherosclerotic 
effects, as uremia has been associated with an increased 
burden of oxidative stress (Himmelfarb et al., 2002). 
individual stenosis of 20-49% was given 
a score of 0.5, 50-69%, 1.0, and >=70%, 
1.5, respectively, and (4) right coronary 
artery (RCA) system (which included the 
RCA, posterior descending artery and 
posterior left ventricular branches); each 
individual stenosis of 20-49% was given a 
score of 0.5, 50-69%, 1.0, and >=70%, 1.5, 
respectively.  If a ramus branch was pres-
ent, each individual stenosis of 20-49% 
was given a score of 0.25, 50-69%, 0.5, 
and >=70%, 0.75. The score for each indi-
vidual lesion was totaled into an overall 
burden of CAD score for each patient. 
The percent stenoses were obtained from 
official catheterization reports from one 
of two experienced interventional cardi-
ologists. The scoring system was consid-
ered “appropriate” by three independent 
cardiologists. The CAD burden score was 
dichotomized at the 75th percentile. 
T-tests and chi square analyses were per-
formed when comparing means and 
proportions of baseline measurements 
between subjects with MI and without MI, and between 
subjects with CAD burdens above and below the 75th 
percentile, respectively. To evaluate the relationships 
between serum BUN and CAD burden, and between 
serum BUN and MI, univariate analyses and multivari-
ate analyses adjusting for baseline characteristics were 
conducted using logistic regression models.  All statisti-
cal analysis was performed with the MDAS Version 2.0 
(eSKay Software TM 2004) statistical software package. 
The Montefiore Medical Center Institutional Review 
Board approved this study.
RESULTS
Baseline characteristics for the entire cohort are pre-
sented in Table 1.  Baseline characteristics for the dichot-
omized CAD burden variable are presented in Table 
2.  The CAD burden score range was 0-19 with a 75th 
percentile of seven.  Subjects with a CAD burden score 
greater than or equal to the 75th percentile were older 
(69.2 years vs. 61.0, p=0.04), had lower CrCl  (75.7 vs. 
100.3, p<0.01), lower BMI  (26.5 vs. 28.9, p<0.01), and 
higher BUN  (20.5 vs. 16.5, p<0.01). 
On univariate analysis, each 1 mg/dl increase in BUN was 
associated with an average increased odds of having a 
CAD burden score greater or equal to the 75th percen-
tile of 12% (OR 1.12 (1.05, 1.19); p<0.01).  On multivari-
ate analysis, which included age, sex, CrCl, body mass 
index, history of smoking, hyperlipidemia, HTN, and 
diabetes, each 1 mg/dl increase in BUN was associated 
with an average increased odds of having a CAD burden 
score greater or equal to the 75th percentile of 9% (OR 
Table 1: Baseline Patient Characteristics
Overall* (n=156)
Age 63.2 (+/-) 13.3
Male 52.6%
Creatinine Clearance (mL/min) 94.0 (+/- 59.7)
Diabetes 28.2%
BMI (kg/m2) 28.3% (+/- 5.9%)
HTN 73.1%
Dyslipidemia 41.6% (2 missing)
Smoking 33.8% (11 missing)
BUN (mg/dl) 17.4 (+/- 6.0)
CAD Burden Score 3.9% (+/- 4.1)
*Three patients are missing cardiac enzymes
BMI = body mass index; BUN = blood urea nitrogen; CAD = coronary artery disease;  
HTN = hypertension
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Table 2: Baseline Patient Characteristics by Dichotomized CAD Burden Score
CAD Score < 75% (n=116) ≥75% (n=40) p value*
Age 61.0 (+/- 13.5) 69.2 (+/- 10.9) 0.04
Male 50.9% 50.0% NS
Creatinine clearance (mL/min) 100.3 (+/- 65.4) 75.7 (+/- 33.1) <0.01
Diabetes 25.7% 35.0% NS
BMI (kg/m2) 28.9 (+/- 6.4) 26.5 (+/- 4.1) <0.01
HTN 71.0% 80.0% NS
Dyslipidemia 39.4% (2 missing) 47.5% NS
Smoking 33.0% (7 missing) 36.1% (4 missing) NS
BUN (mg/dl) 16.5 (+/- 5.2) 20.5 (+/- 7.2) <0.01
*A p value of <0.05 was considered significant 
BMI = body mass index; BUN = blood urea nitrogen; CAD = coronary artery disease;  
HTN = hypertension; NS = not significant
BUN may also both inhibit nitric oxide synthesis and pro-
mote macrophage proliferation (Moeslinger et al., 1999). 
Specifically, in vivo studies demonstrate that increas-
ing levels of urea inhibit nitric oxide synthesis in mouse 
macrophages with concurrent macrophage proliferation 
(Conte et al., 1987). Furthermore, uremia accelerates ath-
erosclerosis in Apolipoprotein E-deficient mice.  
Other studies indicate that uremia induces the expression 
of osteoblast differentiation factor Cbfa1 in the intima 
and media of arteries, which may lead to vascular calcifi-
cation (Moe et al., 2003). Elevated BUN may also serve as 
a marker of an activated sympathetic nervous system and/
or an upregulated renin-angiotensin system, reported 
promoters of atherosclerosis (Kirtane et al., 2005; Ostfeld 
et al., 2006; Manuck et al., 1988; Rozanski et al., 1990; 
Tummala et al., 1999). Activation of these neurohor-
monal systems has been associated with increased BUN 
reabsorption in the renal tubules.
We observed this association between increased BUN 
and CAD while correcting for creatinine clearance. 
Concurrently, Kirtane et al. (2005) reported that increas-
ing BUN predicts poor outcome in subjects with acute 
coronary syndromes despite normal or mildly reduced 
glomerular filtration rates. Consequently, an elevated 
serum BUN may represent an independent marker of 
renal dysfunction, which would further support the well-
established association between renal disease and CAD 
(Anvekar et al., 2004; Foley et al., 2005). However, addi-
tional study is required to evaluate this point.  
Counterintuitively, we found that a reduced BMI was 
associated with both an increased burden of CAD and 
with ruling in for myocardial infarction. This finding may 
be secondary to chance. Alternatively, it may lend support 
to the “obesity paradox,” where overweight or obese 
patients have greater cardiovascular risk yet appear to 
have improved outcomes compared to patients who are 
not overweight or obese (Pingitore et al., 2007).
Our study has several limitations. It is a retrospective 
analysis.  The BUN levels were a single measurement 
and are not necessarily a reflection of one’s chronic 
level. BUN elevation may occur for reasons other than 
neurohormonal up-regulation and/or the presence of 
renal dysfunction, such as bleeding, diuretic or steroid 
use and/or dietary sources (Mark et al., 1994). No patient 
in our study, however, had known active bleeding, or 
was known to be taking loop diuretics or steroids. We 
were unable to account for potential dietary influences 
on serum BUN. Furthermore, our measure of the bur-
den of CAD, as previously reported (Usberti et al., 1985), 
although deemed “appropriate” by three independent 
cardiologists, has not been validated.  However, previous 
studies have utilized a similar scale in grading coronary 
artery lesions based on angiographic findings (Warnholtz 
et al., 1999; Goetz, 1997).
CONCLUSIONS
In conclusion, our study suggests that an elevated serum 
BUN in subjects presenting with signs and symptoms of 
unstable angina and without known CAD may predict a 
larger burden of CAD on cardiac catheterization inde-
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